Activity

Filter

Cancel
Date Panel Item Activity
6 actions
Ataxia - paediatric v0.257 SLC44A1 Zornitza Stark edited their review of gene: SLC44A1: Changed phenotypes: Childhood-onset neurodegeneration, progressive ataxia tremor cognitive decline dysphagia optic atrophy dysarthria, Neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline, MIM# 618868
Ataxia - paediatric v0.211 SLC44A1 Zornitza Stark Marked gene: SLC44A1 as ready
Ataxia - paediatric v0.211 SLC44A1 Zornitza Stark Gene: slc44a1 has been classified as Green List (High Evidence).
Ataxia - paediatric v0.211 SLC44A1 Zornitza Stark Classified gene: SLC44A1 as Green List (high evidence)
Ataxia - paediatric v0.211 SLC44A1 Zornitza Stark Gene: slc44a1 has been classified as Green List (High Evidence).
Ataxia - paediatric v0.210 SLC44A1 Zornitza Stark gene: SLC44A1 was added
gene: SLC44A1 was added to Ataxia - paediatric. Sources: Literature
Mode of inheritance for gene: SLC44A1 was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: SLC44A1 were set to 31855247
Phenotypes for gene: SLC44A1 were set to Childhood-onset neurodegeneration; progressive ataxia tremor cognitive decline dysphagia optic atrophy dysarthria
Review for gene: SLC44A1 was set to GREEN
Added comment: Four affected individuals from three families with homozygous frameshift variants. Functional evidence points to impaired choline transporter function yet unchanged membrane phosphatidylcholine content. Choline treatments may be beneficial.
Sources: Literature